Difference between revisions of "Part:BBa K2842669"
Line 32: | Line 32: | ||
<p> | <p> | ||
− | This DNA construct encodes a C terminal segment of the AceL-TerL intein fused to the N terminus of a mScarlet reporter protein | + | This DNA construct encodes a C terminal segment of the AceL-TerL intein fused to the N terminus of a mScarlet reporter protein which contains a C terminal StrepTag for purification. The AceL-TerL intein acts as a protein ligase that forms a peptide bond between mScarlet and another protein bound to a complementary split intein. During this process the intein splices itself out of protein and is not present in the final fusion protein. This construct is a modular platform for the creation of split intein fusion proteins through the SapI restriction sites located immediately upstream and downstream of the mScarlet reporter.BBa_K2832680 was designed to be used in conjunction with this construct as it contains the corresponding N terminal intein segment to enable intein trans-splicing. |
</p> | </p> | ||
Line 39: | Line 39: | ||
</html> | </html> | ||
__TOC__ | __TOC__ | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
[[File: UCLImprovedPartComparison.png |400px|thumb|left| | [[File: UCLImprovedPartComparison.png |400px|thumb|left| | ||
Line 65: | Line 51: | ||
<br><h3>Experimental Results</h3> | <br><h3>Experimental Results</h3> | ||
− | <p> | + | <p> This construct (BBa_K2842669) is also an improvement of the part [https://parts.igem.org/Part:BBa_K2842669 BBa_K1362101]. Both parts were designed to allow for the modular design and assembly of intein fusion proteins, but our part has distinct advantages and improvements. We used mScarlet as our reporter instead of mRFP1 as it is known to be brighter than mRFP1 and a fast folder. Our reporter protein mScarlet has an 11-fold increase in fluorescence/OD600 compared to BBa_K1362101 when driven by the expression from the T7 promoter (Fig3). Our construct also has a dual function as both an assembly construct and reporter for building new inteins but as an intein fusion by itself. Due to this, it can be used for both to test intein functionality in other constructs and to build new ones. |
− | + | ||
− | Our construct also has a dual function as both an assembly construct and reporter for building new inteins but as an intein fusion by itself. | + | |
</p> | </p> | ||
Line 80: | Line 64: | ||
*edited to show relevant bands | *edited to show relevant bands | ||
</p>''' ]] | </p>''' ]] | ||
+ | |||
+ | <p> | ||
+ | We measured the expression of BBa_K2842669 with a BMG Fluostar plate reader by analysis of it's fluorescence at varying IPTG concentrations. We found that mScarlet is very well expressed when produced from an IPTG-inducible T7 promoter. Increasing IPTG concentrations from 400 uM to 800 uM had little effect on expression levels and cell growth rate (Fig1A, Fig1B), indicating that IPTG concentrations at 400 uM are sufficient to overproduce our protein. We also tested the modularity of the construct by replacing mScarlet with with two new sequences to create the biobricks [https://parts.igem.org/Part:BBa_K2842710 BBa_K2842710] and [https://parts.igem.org/Part:BBa_K2842720 BBa_K2842720]. We have confirmed this assembly with Sanger sequencing. | ||
+ | |||
+ | </p> | ||
+ | |||
+ | [[File:T--UCL--IP_IPTG_Variations.png|400px|thumb|left| | ||
+ | <center>'''Figure 1: Expression of IP at varying IPTG concentrations'''</center> | ||
+ | |||
+ | Initial experiments suggested that 400 uM of IPTG was optimal for expression(data not shown). A plate reader was used to examine the region of IPTG concentrations around 400 uM | ||
+ | </p> | ||
+ | ]] | ||
+ | |||
+ | |||
+ | |||
- | - | ||
+ | |||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
+ | |||
<!-- --> | <!-- --> |
Revision as of 17:22, 17 October 2018
mScarlet reporter with TerL-C intein on the N terminus
mScarlet with TerL-C intein | |
---|---|
Function | Standardised blue-white screening |
Use in | E. coli cells |
Chassis Tested | DH5α cells |
Abstraction Hierarchy | Composite Device |
Related Device | BBa_K1362101 |
RFC standard | RFC10,RFC21,RFC23 & RFC25 compatible |
Backbone | pSB1C3 |
Submitted by | [http://2018.igem.org/Team:UCL UCL iGEM 2018] |
This DNA construct encodes a C terminal segment of the AceL-TerL intein fused to the N terminus of a mScarlet reporter protein which contains a C terminal StrepTag for purification. The AceL-TerL intein acts as a protein ligase that forms a peptide bond between mScarlet and another protein bound to a complementary split intein. During this process the intein splices itself out of protein and is not present in the final fusion protein. This construct is a modular platform for the creation of split intein fusion proteins through the SapI restriction sites located immediately upstream and downstream of the mScarlet reporter.BBa_K2832680 was designed to be used in conjunction with this construct as it contains the corresponding N terminal intein segment to enable intein trans-splicing.
Contents
Experimental Results
This construct (BBa_K2842669) is also an improvement of the part BBa_K1362101. Both parts were designed to allow for the modular design and assembly of intein fusion proteins, but our part has distinct advantages and improvements. We used mScarlet as our reporter instead of mRFP1 as it is known to be brighter than mRFP1 and a fast folder. Our reporter protein mScarlet has an 11-fold increase in fluorescence/OD600 compared to BBa_K1362101 when driven by the expression from the T7 promoter (Fig3). Our construct also has a dual function as both an assembly construct and reporter for building new inteins but as an intein fusion by itself. Due to this, it can be used for both to test intein functionality in other constructs and to build new ones.
We measured the expression of BBa_K2842669 with a BMG Fluostar plate reader by analysis of it's fluorescence at varying IPTG concentrations. We found that mScarlet is very well expressed when produced from an IPTG-inducible T7 promoter. Increasing IPTG concentrations from 400 uM to 800 uM had little effect on expression levels and cell growth rate (Fig1A, Fig1B), indicating that IPTG concentrations at 400 uM are sufficient to overproduce our protein. We also tested the modularity of the construct by replacing mScarlet with with two new sequences to create the biobricks BBa_K2842710 and BBa_K2842720. We have confirmed this assembly with Sanger sequencing.
-
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NotI site found at 941
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI site found at 1224
Illegal BsaI.rc site found at 28
Illegal SapI site found at 1130
Illegal SapI.rc site found at 419